IceCure Medical Ltd Stock TEL AVIV STOCK EXCHANGE
Stocks
ICCM
IL0011224156
Advanced Medical Equipment & Technology
| Market Cap | 7.54M 0 6.49M 6.09M 5.57M 10.39M 713M 10.48M 72.01M 28.04M 364M 28.31M 27.69M 1.17B | P/E 2026 * |
-0.4x | P/E 2027 * | -0.64x |
|---|---|---|---|---|---|
| Enterprise Value | 7.54M 0 6.49M 6.09M 5.57M 10.39M 713M 10.48M 72.01M 28.04M 364M 28.31M 27.69M 1.17B | EV / Sales 2026 * |
1.76x | EV / Sales 2027 * | 0.86x |
| Free-Float |
54.2% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : IceCure Medical Ltd
| Manager | Title | Age | Since |
|---|---|---|---|
Eyal Shamir
CEO | Chief Executive Officer | 65 | 2016-08-31 |
Meir Peleg
DFI | Director of Finance/CFO | 50 | 2026-05-16 |
Shay Levav
COO | Chief Operating Officer | 49 | 2025-11-04 |
| Director | Title | Age | Since |
|---|---|---|---|
Eyal Shamir
BRD | Director/Board Member | 65 | 2017-12-04 |
| Chairman | 62 | 2017-12-04 | |
Sharon Levita
BRD | Director/Board Member | 57 | 2019-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -6.22% | - | - | 7.54M | |
| +1.63% | -1.95% | +27.63% | +10.98% | 229B | |
| +0.53% | -2.16% | +5.81% | -20.54% | 148B | |
| -0.55% | +0.75% | -16.17% | +19.14% | 131B | |
| -2.94% | +0.60% | -56.34% | -12.44% | 68.04B | |
| -1.15% | -0.19% | +10.54% | +17.54% | 51.75B | |
| +0.76% | -1.16% | -17.14% | -14.29% | 50.21B | |
| -0.93% | -4.89% | +19.77% | +23.03% | 42.28B | |
| +0.33% | -1.83% | +42.58% | +47.16% | 40.63B | |
| -0.73% | -2.79% | -14.87% | +43.97% | 33.06B | |
| Average | -0.30% | -1.35% | +0.20% | +12.73% | 88.18B | |
| Weighted average by Cap. | +0.14% | -1.78% | +3.77% | +7.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.3M 0 3.7M 3.47M 3.17M 5.92M 406M 5.97M 41.02M 15.98M 207M 16.13M 15.78M 668M | 8.8M 0 7.57M 7.11M 6.5M 12.14M 832M 12.23M 84.08M 32.75M 425M 33.06M 32.34M 1.37B |
| Net income | -17.66M -0 -15.19M -14.26M -13.04M -24.35M -1.67B -24.54M -169M -65.68M -853M -66.31M -64.86M -2.75B | -16.34M -0 -14.06M -13.19M -12.07M -22.52M -1.54B -22.7M -156M -60.77M -789M -61.35M -60.01M -2.54B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
